In addition, patients with lung adenocarcinoma lack antitumor innate immunity at baseline including tumor-infiltrating NK cells, which are less cytolytic due to low expression of granzyme B and interferon-gamma [29]. The gene discussed is IFNG; the disease is neoplasm.